Fitness Costs of Mutations at the HIV-1 Capsid Hexamerization Interface

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Manocheewa, Siriphan ^a   Swain, J Victor ^a   Lanxon Cookson, Erinn ^a   Rolland, Morgane ^a,b   Mullins, James I ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b US Military HIV Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMER; POLYMER; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CHEMICAL STRUCTURE; HEXAMERIZATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; MOLECULAR INTERACTION; MUTATION; NONHUMAN; POLYMERIZATION; VIRUS CAPSID; VIRUS REPLICATION;

AMINO ACID SUBSTITUTION; CAPSID; CAPSID PROTEINS; CELL LINE; GENETIC FITNESS; HIV-1; HUMANS; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; RECOMBINATION, GENETIC; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 84878978349     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066065     Document Type: Article

References (33)

1. Ganser-Pornillos BK, Yeager M, Sundquist WI, (2008) The structural biology of HIV assembly. Curr Opin Struct Biol 18: 203-217.
2. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI, (1999) Assembly and analysis of conical models for the HIV-1 core. Science 283: 80-83.
3. Briggs JA, Wilk T, Welker R, Krausslich HG, Fuller SD, (2003) Structural organization of authentic, mature HIV-1 virions and cores. EMBO J 22: 1707-1715.
4. Berthet-Colominas C, Monaco S, Novelli A, Sibai G, Mallet F, et al. (1999) Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J 18: 1124-1136.
5. Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, et al. (2009) X-ray structures of the hexameric building block of the HIV capsid. Cell 137: 1282-1292.
6. Forshey BM, von Schwedler U, Sundquist WI, Aiken C, (2002) Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol 76: 5667-5677.
7. von Schwedler UK, Stray KM, Garrus JE, Sundquist WI, (2003) Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol 77: 5439-5450.
8. Bartonova V, Igonet S, Sticht J, Glass B, Habermann A, et al. (2008) Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein. J Biol Chem 283: 32024-32033.
9. Tang S, Murakami T, Agresta BE, Campbell S, Freed EO, et al. (2001) Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells. J Virol 75: 9357-9366.
10. Bocanegra R, Rodriguez-Huete A, Fuertes MA, Del Alamo M, Mateu MG (2012) Molecular recognition in the human immunodeficiency virus capsid and antiviral design. Virus Res.
11. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, et al. (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68: 4650-4655.
12. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, et al. (2007) CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13: 46-53.
13. Liu Y, McNevin J, Cao J, Zhao H, Genowati I, et al. (2006) Selection on the human immunodeficiency virus type 1 proteome following primary infection. J Virol 80: 9519-9529.
14. Allen TM, Altfeld M, Geer SC, Kalife ET, Moore C, et al. (2005) Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol 79: 13239-13249.
15. Rolland M, Nickle DC, Mullins JI, (2007) HIV-1 Group M Conserved Elements Vaccine. PLoS Pathogens 3: e157.
16. Mothe B, Llano A, Ibarrondo J, Zamarreno J, Schiaulini M, et al. (2012) CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control. PLoS ONE 7: e29717.
17. Laskowski RA, (2009) PDBsum new things. Nucleic Acids Res 37: D355-359.
18. Maddison WP, Maddison DR (2011) Mesquite: a modular system for evolutionary analysis. 2.75 ed.
19. Nickle DC, Jensen MA, Gottlieb GS, Shriner D, Learn GH, et al. (2003) Consensus and ancestral state HIV vaccines. Science 299: 1515-1518; author reply 1515-1518.
20. Deng W, Maust BS, Nickle DC, Learn GH, Liu Y, et al. (2010) DIVEIN: A Web Server to Analyze Phylogenies, Sequence Divergence, Diversity, and Informative Sites. Biotechniques 48: 405-408.
21. McClure J, van't Wout AB, Tran T, Mittler JE, (2007) Granulocyte-monocyte colony-stimulating factor upregulates HIV-1 replication in monocyte-derived macrophages cultured at low density. J Acquir Immune Defic Syndr 44: 254-261.
22. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27: 493-497.
23. Troyer RM, McNevin J, Liu Y, Zhang SC, Krizan RW, et al. (2009) Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog 5: e1000365.
24. Liu Y, Mullins JI,etal (2012) A sensitive real-time PCR based assay to estimate the impact of amino acid substitutions on the competitive replication fitness of human immunodeficiency virus type 1 in cell culture. Journal of Virological Methods: In Press.
25. Ma J, Dykes C, Wu T, Huang Y, Demeter L, et al. (2010) vFitness: a web-based computing tool for improving estimation of in vitro HIV-1 fitness experiments. BMC Bioinformatics 11: 261.
26. Wu H, Huang Y, Dykes C, Liu D, Ma J, et al. (2006) Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay. J Virol 80: 2380-2389.
27. Rolland M, Jensen MA, Nickle DC, Yan J, Learn GH, et al. (2007) Reconstruction and function of ancestral center-of-tree human immunodeficiency virus type 1 proteins. J Virol 81: 8507-8514.
28. Carlson JM, Brumme ZL, Rousseau CM, Brumme CJ, Matthews P, et al. (2008) Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag. PLoS Comput Biol 4: e1000225.
29. Pornillos O, Ganser-Pornillos BK, Yeager M, (2011) Atomic-level modelling of the HIV capsid. Nature 469: 424-427.
30. Bailey GD, Hyun JK, Mitra AK, Kingston RL, (2012) A structural model for the generation of continuous curvature on the surface of a retroviral capsid. J Mol Biol 417: 212-223.
31. Rolland M, Manocheewa S, Swain JV, Lanxon-Cookson EC, Kim M, et al. (2013) HIV-1 conserved elements vaccines: Relationship between sequence conservation and replicative capacity. J Virol.
32. Mothe B, Llano A, Ibarrondo J, Daniels M, Miranda C, et al. (2011) Definition of the viral targets of protective HIV-1-specific T cell responses. J Transl Med 9: 208.
33. Niu L, Termini JM, Kanagavelu SK, Gupta S, Rolland MM, et al. (2011) Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes. Vaccine 29: 2110-2119.